Since publication of our article \[[@B1]\], we have realised that we did not include the full data in Table [1](#T1){ref-type="table"} and missed the word (TOF) in the result/discussion section. We have provided here the adapted sentence and another version of the table, including all the information intended.

###### 

The representative molecular weights of the proteins identified in the mRNA Microarray study \[Thirteen\] \[[@B2]\]

  --------------------------------------------------------------------------------------------------
  Protein                                                                   Mass in Da
  ------------------------------------------------------------------------- ------------------------
  **Osteoglycin (OGN/4969)**                                                33,922

  **Interleukin-6 signal transducer (IL6ST/3572)**                          isoform 1 103,537\
                                                                            isoform 2 37,499

  **Cytochrome P450, Family 2, Subfamily J, polypeptide 2 (CYP2J2/1573)**   57,611

  **Carboxypeptidase E (CPE/1363)**                                         53,151

  **Fibronectin 1 (FN1/2335)**                                              **different isoforms**

                                                                             1. 262,607

                                                                             2. 71,943

                                                                             3. 259,198

                                                                             4. 222,944

                                                                             5. 243,316

                                                                             6. 240,477

                                                                             7. 268,894

                                                                             8. 252,793

                                                                             9. 246,670

                                                                             10. 239,608

                                                                             11. 262,388

                                                                             12. 221,274

                                                                             13. 249,304

                                                                             14. 249,384

                                                                             15. 272,302

  **Synuclein, gamma (SNCG/6623)**                                          13,331

  **BAI1-associated protein 2 (BAIAP2/10458)**                              **different isoforms**

                                                                             1. 60,868

                                                                             2. 59,014

                                                                             3. 56,626

                                                                             4. 57,359

                                                                             5. 57,445

                                                                             6. 57,430

  **Protocadherin 17 (PCDH17/27253)**                                       **different isoforms**

                                                                             1. 126,229

                                                                             2. 96,570

  **Protein tyrosine phosphatase, receptor type, R (PTPRR/5801)**           Alpha 73,834 Da\
                                                                            Gamma 46,581Da\
                                                                            Delta 51,046Da
  --------------------------------------------------------------------------------------------------

Results/Discussion
==================

\"Therefore, we plan to repeat this study in a larger sample size including well defined endometrial samples obtained during menstrual, follicular and secretory phase, to validate the reproducibility of SELDI-TOF MS technology in these samples and to identify the protein peaks observed after proteomic analysis, which are expensive and labour intense requiring High-performance liquid chromatography or high-pressure liquid chromatography (HPLC) and matrix assisted laser desorption ionization Time-of-Flight-Mass Spectrometry (MALDI-TOF/TOF MS).\"
